Cargando…

Biventricular dimensions and function in pediatric sickle-cell disease and thalassemia major patients without cardiac iron

Detalles Bibliográficos
Autores principales:	Meloni, Antonella, Detterich, Jon, Berdoukas, Vasili, Pepe, Alessia, Lombardi, Massimo, Coates, Thomas D, Wood, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559702/ http://dx.doi.org/10.1186/1532-429X-15-S1-P111

Ejemplares similares

Treating thalassemia major-related iron overload: the role of deferiprone
por: Berdoukas, Vasilios, et al.
Publicado: (2012)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Different patterns of myocardial iron overload by T2* Cardiovascular MR as markers of risk for cardiac complication in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2012)

Regional myocardial contractility in Thalassemia Major by magnetic resonance tagging
por: Meloni, Antonella, et al.
Publicado: (2014)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Right ventricular wall motion abnormalities n Thalassemia Major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
por: Smith, Gillian C, et al.
Publicado: (2011)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
por: Aessopos, Athanasios, et al.
Publicado: (2009)

Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Different patterns of myocardial iron overload by multislice T2* Cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2011)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Successful chelation in beta-thalassemia major in the 21(st) century
por: Fragodimitri, Christina, et al.
Publicado: (2023)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
por: Pepe, Alessia, et al.
Publicado: (2011)

An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

T2* heterogeneity detected by CMR could be related to myocardial iron distribution in Thalassemia patients
por: Positano, Vincenzo, et al.
Publicado: (2009)

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Left Ventricular Volumes, Mass and Function normalized to the body surface area, age and gender from CMR in a large cohort of well-treated Thalassemia Major patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Iron Metabolism in Thalassemia and Sickle Cell Disease.
por: Mariani, Raffaella, et al.
Publicado: (2009)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy
por: Farmaki, Kallistheni, et al.
Publicado: (2008)

Significant improvement of survival by T2* CMR in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2016)

Changes of cardiac iron and function during pregnancy in trasfusion-dependent thalassemia patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM)
por: Giakoumis, Anastasios, et al.
Publicado: (2007)

Autonomic responses to cold face stimulation in sickle cell disease: a time-varying model analysis
por: Chalacheva, Patjanaporn, et al.
Publicado: (2015)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Aortic pulse wave velocity assessment in CMR: a novel method for transit time estimation
por: Meloni, Antonella, et al.
Publicado: (2013)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mksh25fgnfihqja3b5n63tocpj